Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Gene therapy for cardiac cachexia?

Nadia Rosenthal1, Antonio Musarò

  • 1Mouse Biology Programme, European Molecular Biology Laboratory (EMBL), Monterotondo, Rome, Italy. rosenthal@embl-monterotondo.it

International Journal of Cardiology
|August 7, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A 3D skeletal muscle system for disease modelling and secretome profiling of Duchenne muscular dystrophy.

Skeletal muscle·2026
Same author

Transforming growth factor β induced as a novel secreted immune checkpoint counterinhibiting human tumor-associated T cells.

Journal for immunotherapy of cancer·2026
Same author

T-regulatory cell protection of progenitor cells from CD4 <sup>+</sup> T-cell-mediated cytotoxicity is essential for endogenous mouse digit-tip regeneration.

bioRxiv : the preprint server for biology·2025
Same author

Advancing biological understanding of cellular senescence with computational multiomics.

Nature genetics·2025
Same author

Resistin-like molecule γ attacks cardiomyocyte membranes and promotes ventricular tachycardia.

Science (New York, N.Y.)·2025
Same author

Sustained Lung Inflammation Post-SARS-CoV-2 Infection in Mice Is Associated with Increased Pulmonary T Cells.

European journal of immunology·2025

Gene therapy using local insulin-like growth factor-1 (IGF-1) shows promise for preventing muscle loss in cardiac cachexia. This approach avoids systemic side effects associated with growth hormone treatments.

Area of Science:

  • Biomedical Science
  • Molecular Biology
  • Regenerative Medicine

Background:

  • Cardiac cachexia causes significant skeletal muscle degeneration.
  • Current cell-based therapies face challenges with cell numbers and integration.
  • Systemic growth hormone and insulin-like growth factor-1 (IGF-1) therapies have safety concerns.

Purpose of the Study:

  • To explore the therapeutic potential of locally expressed IGF-1 for muscle degeneration.
  • To evaluate a gene-based approach to prevent or attenuate muscle loss in disease models.

Main Methods:

  • Utilized mouse models with muscle-specific transgene expression of a locally acting IGF-1 isoform.
  • Assessed the effects on muscle hypertrophy, age-related atrophy, and stem cell recruitment.

Related Experiment Videos

Main Results:

  • Selective expression of muscle-specific IGF-1 induced muscle hypertrophy.
  • Prevented age- and disease-related muscle atrophy by enhancing stem cell recruitment.
  • Avoided hypertrophic effects on the heart and risks associated with circulating IGF-1.

Conclusions:

  • Local IGF-1 gene therapy offers a targeted strategy for muscle regeneration.
  • This approach presents a safer alternative to systemic growth hormone/IGF-1 administration.
  • Further research into locally expressed IGF-1 is warranted for cardiac cachexia treatment.